Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Hspg2
REST API REST API
Mus musculus
Hspg2 is differentially expressed in 225 experiments: 87 organism parts: liver, spleen, ... (85 more);, 13 disease states: normal, 3-NP-induced neurodegeneration model of Huntington's disease, ... (11 more);, 64 cell types 19 cell lines 25 compound treatments and 39 other conditions.
Synonyms 'Plc', 'Pcn', 'per'
Orthologs HSPG2 (Gallus gallus)   HSPG2 (Homo sapiens)   F1M566_RAT (Rattus norvegicus)   HSPG2 (Bos taurus)   hspg2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term angiogenesis, protein localization, protein binding, extracellular space, proteinaceous extracellular matrix, extracellular region, basal lamina, cardiac muscle tissue development, basement membrane, cell adhesion, protein C-terminus binding, extracellular matrix organization, extracellular matrix, brain development, calcium ion binding, endochondral ossification, chondrocyte differentiation, embryonic skeletal system morphogenesis, cartilage development involved in endochondral bone morphogenesis
InterPro Term Ig_V-set, SEA, Ig_sub, EGF_laminin, Immunoglobulin, Laminin_B_type_IV, Laminin_G, Ig-like, EGF, Laminin_B_subgr, Ig_sub2, Laminin_G_2, EGF_3, EGF-like, Ig_I-set, Laminin_G_1, Ig_V-set_subgr, LDrepeatLR_classA_rpt, EGF-like_Ca-bd
Search EB-eye ENSMUSG00000028763
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-20160, E-GEOD-3963, E-MEXP-1636, ... (52 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-MEXP-1689, E-GEOD-21515, E-GEOD-19732, E-GEOD-10246, E-MEXP-1361, ... (7 experiments)

Factor Value U/D Experiments
R10
1
E-MEXP-1689
66cl4
1
1
E-GEOD-11259
Swiss9
1
E-GEOD-19732
R1
1
E-GEOD-21515
Swiss19
1
E-GEOD-19732
M-27-IGF-IR
1
E-MEXP-1361
13 more value(s).


Cell type

studied in E-GEOD-19401, E-GEOD-7764, E-GEOD-7069, E-GEOD-21749, E-TABM-130, ... (21 experiments)

Factor Value U/D Experiments
amygdala
1
E-GEOD-10246
T effector cell
1
E-GEOD-1419
brown preadipocyte
1
E-GEOD-7032
GABAergic interneuron
1
1
E-GEOD-2882
type B spermatogonia
1
E-GEOD-4193
resting natural killer cell
1
E-GEOD-7764
58 more value(s).


Disease state

studied in E-GEOD-21927, E-GEOD-21902, E-GEOD-21543, E-MEXP-1137, E-GEOD-2528, ... (10 experiments)

Factor Value U/D Experiments
breast carcinoma
1
E-GEOD-2528
mouse model of Huntington's disease
1
E-GEOD-3583
LPS-induced acute lung injury
1
1
E-GEOD-1871
MMTV-Myc
1
1
E-GEOD-15904
multiple myeloma
1
E-GEOD-6980
tumor
1
E-GEOD-21902
7 more value(s).


Compound treatment

studied in E-GEOD-21927, E-GEOD-2565, E-TABM-903, E-MEXP-2192, E-MEXP-2209, ... (20 experiments)

Factor Value U/D Experiments
cardiotoxin
2
E-MEXP-703, E-GEOD-5304
none
3
4
E-MEXP-1137, E-GEOD-21927, E-MEXP-703, E-GEOD-5304, E-GEOD-2973, ... (7 experiments)
control
2
3
E-GEOD-21710, E-GEOD-5041, E-TABM-903, E-GEOD-7694, E-GEOD-2411 ... (5 experiments)
lipopolysaccharide
1
E-GEOD-2411
dexamethasone
1
E-MEXP-774
ethanol
1
E-MEXP-774
19 more value(s).


Agent

studied in E-GEOD-26086, E-GEOD-32706

Factor Value U/D Experiments
fish oil
1
1
E-GEOD-32706
CD71-24_4h_100nMDex_333uMDMOG
1
1
E-GEOD-26086
CD71_4h_100nMDex
1
1
E-GEOD-26086
not specified
1
E-GEOD-26086
CD71-24_4h_100nMDex
1
1
E-GEOD-26086
CD71-24_4h_333uMDMOG
1
1
E-GEOD-26086
1 more value(s).


Amount to core
studied in E-GEOD-18858

Bioanalyzer results
studied in E-GEOD-18858

Clinical info
studied in E-MEXP-1458

Clinical treatment
studied in E-GEOD-3075, E-GEOD-2411

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-GEOD-5668, E-GEOD-1026, E-GEOD-1867, E-GEOD-5305, E-GEOD-8191, ... (21 experiments)

Diet
studied in E-GEOD-16377

dose or concentration
studied in E-GEOD-18858

Family history
studied in E-GEOD-19194

Generation
studied in E-GEOD-6527

Genetic modification
studied in E-GEOD-2188

Genotype
studied in E-GEOD-7020, E-MEXP-1649, E-TABM-285, E-GEOD-19194, E-MEXP-856, ... (33 experiments)

Growth condition
studied in E-GEOD-1867, E-GEOD-4310

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Infection
studied in E-MEXP-1190, E-GEOD-17049, E-GEOD-4324, E-MEXP-1942, E-GEOD-2973 ... (5 experiments)

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-3594, E-GEOD-5296

Organism
studied in E-MEXP-667

Phenotype
studied in E-GEOD-272, E-GEOD-2640, E-GEOD-19979

Protocol type
studied in E-GEOD-16192, E-GEOD-2917

Rna integrity number
studied in E-GEOD-18858

RNAi
studied in E-MEXP-1342

Route of exposure
studied in E-GEOD-18858

Sex
studied in E-GEOD-3530

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902, E-GEOD-15901

Strain or line
studied in E-GEOD-17936, E-GEOD-5429, E-TABM-671, E-GEOD-21515, E-GEOD-21278, ... (10 experiments)

Transfect
studied in E-GEOD-6487

Treatment
studied in E-GEOD-21902, E-GEOD-18344, E-GEOD-22009, E-GEOD-21841, E-MEXP-1899, ... (8 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.202 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM